YORSAVAK Trademark

Trademark Overview

On Wednesday, September 29, 2021, a trademark application was filed for YORSAVAK with the United States Patent and Trademark Office. The USPTO has given the YORSAVAK trademark a serial number of 97052014. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 3, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The YORSAVAK trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
yorsavak

General Information

Serial Number97052014
Word MarkYORSAVAK
Filing DateWednesday, September 29, 2021
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2024

Trademark Statements

Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events

Event DateEvent Description
Saturday, October 2, 2021NEW APPLICATION ENTERED
Wednesday, October 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 29, 2022ASSIGNED TO EXAMINER
Wednesday, July 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 9, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 9, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 4, 2023SOU EXTENSION 1 FILED
Tuesday, April 4, 2023SOU EXTENSION 1 GRANTED
Thursday, April 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 20, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 20, 2023SOU EXTENSION 2 FILED
Wednesday, September 20, 2023SOU EXTENSION 2 GRANTED
Friday, September 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 21, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, April 3, 2024SOU EXTENSION 3 FILED
Wednesday, April 3, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 11, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 11, 2024SOU EXTENSION 3 GRANTED
Friday, April 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 22, 2024ASSIGNED TO PETITION STAFF
Wednesday, April 24, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, April 24, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, July 25, 2024NOTICE OF ALLOWANCE CANCELLED
Thursday, July 25, 2024CASE RETURNED TO EXAMINATION
Wednesday, August 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

yorsavak preparations treatment pharmaceutical diseases disorders oncological neurological respiratory hepatological gastrointestinal